ADA and B-cell chronic lymphocytic leukemia: However, several clinical successes since 2006, including treatments of patients with the retinal disease Leber's congenital amaurosis2, 3, ADA-SCID4, chronic lymphocytic leukemia (CLL)5, Parkinson's disease6, etc., have bolstered new optimism in the promise of gene therapy.